Page 55 - IMO-2-1

Innovative Medicines & Omics Current approach in the management of kidney disease

67. Rahdar A, Hasanein P, Bilal M, Beyzaei H, Kyzas GZ. a potential medicinal plant: A review. Molecules.
Quercetin-loaded F127 nanomicelles: Antioxidant activity 2020;25(2):301.
and protection against renal injury induced by gentamicin doi: 10.3390/molecules25020301
in rats. Life Sci. 2021;276:119420.
73. Nirumand MC, Hajialyani M, Rahimi R, et al. Dietary
doi: 10.1016/j.lfs.2021.119420
plants for the prevention and management of kidney stones:
68. Chen YQ, Chen HY, Tang QQ, et al. Protective effect of Preclinical and clinical evidence and molecular mechanisms.
quercetin on kidney diseases: From chemistry to herbal Int J Mol Sci. 2018;19(3):765.
medicines. Front Pharmacol. 2022;13:968226.
doi: 10.3390/ijms19030765
doi: 10.3389/fphar.2022.968226
74. Chitiala RD, Burlec AF, Nistor A, et al. Chemical assessment
69. Yang H, Song Y, Liang YN, Li R. Quercetin treatment and biologic potential of a special Lespedeza capitata extract.
improves renal function and protects the kidney in a rat Med Surg J. 2023;127(3):474-479.
model of adenine-induced chronic kidney disease. Med Sci 75. Mitra P, Jana S, Roy S. Insights into the therapeutic uses
Monit. 2018;24:4760-4766.
of plant derive phytocompounds on diabetic nephropathy.
doi: 10.12659/MSM.909259 Curr Diabetes Rev. 2024;20(9):e230124225973.
70. Cao YL, Lin JH, Hammes HP, Zhang C. Flavonoids doi: 10.2174/0115733998273395231117114600
in treatment of chronic kidney disease. Molecules. 76. Jana S, Mitra P, Panchali T, et al. Evaluating anti-inflammatory
2022;27(7):2365.
and anti-oxidative potentialities of the chloroform fraction
doi: 10.3390/molecules27072365 of Asparagus racemosus roots against cisplatin induced acute
kidney injury. J Ethnopharmacol. 2025;339:119084.
71. Albarakati AJA, Baty RS, Aljoudi AM, et al. Luteolin protects
against lead acetate-induced nephrotoxicity through doi: 10.1016/j.jep.2024.119084
antioxidant, anti-inflammatory, anti-apoptotic, and Nrf2/ 77. Górriz JL, Soler MJ, Navarro-González JF, et al. GLP-1
HO-1 signaling pathways. Mol Biol Rep. 2020;47(4):2591-2603.
receptor agonists and diabetic kidney disease: A call of
doi: 10.1007/s11033-020-05346-1 attention to nephrologists. J Clin Med. 2020;9(4):947.
72. Khalil N, Bishr M, Desouky S, Salama O. Ammi Visnaga L., doi: 10.3390/jcm9040947

Volume 2 Issue 1 (2025) 49 doi: 10.36922/imo.4969